2024-10-16 10:00
US FDA pauses Novavax’s trial of combo COVID-flu shot on safety concerns
(Reuters) – The U.S. Food and Drug Administration has put Novavax’s trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company said on Wednesday. Shares of the vaccine maker…